Understanding how CPSF6 affects HIV infection
Deciphering the Role of CPSF6 in HIV Infection
This study is looking at a protein called CPSF6 to see how it helps the HIV virus infect cells and avoid the immune system, which could lead to new ways to treat HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10883707 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called CPSF6 in the lifecycle of HIV, particularly how it interacts with the virus and influences its ability to infect cells. The study aims to uncover the mechanisms by which CPSF6 affects the immune response to HIV, using advanced techniques like CRISPR to manipulate CPSF6 levels in CD4+ T cells. By examining these interactions, the research seeks to clarify how CPSF6 may help the virus evade the immune system and enhance its replication. The findings could provide insights into new therapeutic strategies for HIV treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV, particularly those with varying responses to current treatments.
Not a fit: Patients who are not infected with HIV or those who have already achieved viral suppression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new approaches for treating HIV by targeting the mechanisms that the virus uses to evade the immune response.
How similar studies have performed: While the specific role of CPSF6 in HIV infection is still being explored, similar research approaches using CRISPR technology have shown promise in other viral studies.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Hultquist, Judd F — Northwestern University at Chicago
- Study coordinator: Hultquist, Judd F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.